Why the study?
Cardiovascular disease disparities between black and white Americans have persisted for decades, but mitigating this disparity through clinical versus non-clinical interventions remains largely untested.
Does the presence of favorable social determinants of health mitigate the disparity in CVD mortality between black and white Americans?
Does the presence of favorable social determinants of health mitigate the disparity in CVD mortality between black and white Americans?
Favorable social determinants of health, rather than clinical risk factor control alone, appear to mitigate the disparity in CVD mortality between black and white Americans.
No takes yet. Share an insight, caveat, or question.
Favorable SDOH may attenuate racial CVD mortality disparities beyond clinical targets; leaves open whether interventions on social factors narrow gaps.
Mousavi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: